OS
OSRHW
OSR Holdings, Inc.
$0.0582
+4.49%
$2.0M
No data for this timeframe.
Vol
Market Cap$2.0M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$69.00
SEC Reports3
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001840425·Prev Close $0.0557
Recent Activity
Jun 2, 2026
SEC
OSR Holdings entered into an Asset Purchase Agreement with its indirect subsidiary Vaximm AG to acquire the VXM01 intell
8-K — Impact 3/10
Apr 30, 2026
SEC
OSR Holdings entered into a global exclusive license agreement with its largest shareholder, BCM Europe, for its VXM01 o
8-K — Impact 5/10
Apr 9, 2026
SEC
OSR Holdings issued a $1.06M senior secured convertible note to White Lion Capital, funded by $500K in cash and the canc
8-K — Impact 5/10
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $69.00 | — |
1 institutional holders with $69.00 total value (1,676 shares) as of 2025-Q3. Top holders: UBS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 1,676 | $69.00 | 100.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 2 neutral. Avg impact: 4.3/10.
NEUTRAL
8-K
3/10
OSR Holdings entered into an Asset Purchase Agreement with its indirect subsidiary Vaximm AG to acqu
Jun 2, 2026
MIXED
8-K
5/10
OSR Holdings entered into a global exclusive license agreement with its largest shareholder, BCM Eur
Apr 30, 2026
NEUTRAL
8-K
5/10
OSR Holdings issued a $1.06M senior secured convertible note to White Lion Capital, funded by $500K
Apr 9, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.